DiviDrip · PHAR

PHAR — Pharming Group N.V.

PHAR is Pharming Group N.V. (Healthcare) — a non-dividend-paying stock. Trading at $11.70. Market cap: $828M. Capital Quality Rank: 100/100 — Market alpha.

Stock snapshot

Price$11.70
Market cap$828M
SectorHealthcare
ExchangeNGM
Pays dividendNo

Capital Quality & fundamentals

DiviDrip's Capital Analytics engine ranks every non-dividend stock 1-100 on a 4-factor composite (Shareholder Yield 30%, Cash-Flow ROI 25%, Operating Momentum 25%, Tail-Risk 20%) — sector-neutralized so a biotech isn't penalized for negative earnings the way a utility would be.

Capital Quality Rank (1-100)100 / 100 · Market alpha
ROIC (TTM)9.1%
Revenue CAGR (3y)22.3%
Shareholder buyback yield15.00%
Altman Z-score zoneGrey

About PHAR

Pharming Group is a biotechnology company focused on developing and commercializing therapies for rare and ultra-rare diseases, particularly immunological and genetic conditions with high unmet need. It operates as an integrated company with capabilities across clinical development, manufacturing, regulatory affairs, and commercialization, supported by scientific and operational expertise. It leverages its efficient infrastructure to expand its pipeline and improve patient access to treatment. The Company operates in the United States, Europe, and the rest of the world, with the United States contributing the majority of its revenue.

Listed2020Employees409SectorHealthcareWebsitepharming.com

Related non-dividend companies

Other non-dividend stocks investors research alongside PHAR. Peer set from Massive news + returns similarity, filtered to names we currently track.

Frequently asked

What is PHAR's current stock price?

PHAR (Pharming Group N.V.) is currently trading at $11.70.

Does PHAR pay a dividend?

PHAR (Pharming Group N.V.) does not currently pay a regular dividend.

What is PHAR's Capital Quality Rank?

PHAR has a Capital Quality Rank of 100/100 — Market alpha. This score blends ROIC, revenue growth, buybacks, and balance-sheet health.

Track PHAR in DiviDrip

Add PHAR to your watchlist on DiviDrip to monitor price, fundamentals, and Capital Quality Rank week-over-week. Built for long-term investors tracking both dividend and non-dividend names.

Data refreshed 2026-08-30. Not investment advice. Prices change continuously; always verify the latest numbers in the live app before buying.

Related guides

DiviDrip is a free dividend portfolio tracker built by dividend investors, for dividend investors. Try it free — no payment, no upsell, ever. Read the How-To to see how each tool fits together, or browse the Glossary for every term defined plain-English.

Disclaimer: The information provided on this website/service is for informational purposes only and does not constitute financial, investment, or legal advice. Investing in stocks involves high risk, including the loss of principal. We are not responsible for any financial losses or damages resulting from your reliance on this data. Always consult with a qualified financial professional before making investment decisions.

Trademark Notice: Twylight Crow's Dividend Tracker (formerly indexed as DiviDrip) is an independent portfolio utility. This tool is not affiliated with, authorized, endorsed by, or in any way officially connected to Dividrip.com or its international affiliates.

Contact: dividrip@twylightcrow.com© 2026 Twylight Crow